ThreeD Capital
VC Fund
Toronto, Canada
ThreeD Capital is a publicly-traded Toronto-based venture capital firm focused on investments in companies in the areas of junior resources, blockchain, psychedelics, artificial intelligence and electric vehicles, among other areas. ThreeD Capital is led by Founder, Chairman and Chief Executive Officer, Sheldon Inwentash, who has financed hundredsof private and public start-up companies.ThreeD Capital provides small cap investors with significant exposure to ground floor opportunities involving early-stage, promising companies.ThreeD Capital follows a merchant banking model which has a high barrier for entry but can quickly become very lucrative. Through this model, ThreeD Capital adopts a fluid investment strategy. They are actively involved with their clients by providing advice and the powerful network that becomes available through working with ThreeD.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries ThreeD Capital invests in
Stages ThreeD Capital invests in
Countries ThreeD Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Post-IPO Debt
- $435k–$520k
- Post-IPO Equity
- $450k–$2.5M
Investment Focus
Industry
- Information Technology 3 (50%)
- FinTech 2 (33%)
- Health Care 2 (33%)
- Biotechnology 2 (33%)
- Financial Services 2 (33%)
Stage
- Post-IPO Equity 2 (33%)
- Seed 1 (17%)
- Post-IPO Debt 1 (17%)
- Venture - Series Unknown 1 (17%)
Country
- Canada 2 (33%)
- Taiwan 1 (17%)
- South Africa 1 (17%)
- United States 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Sheldon Inwentash
Chairman, CEO, & CIO
|
Chairman, CEO, & CIO | Total investments: 1 | Find email | |
|
Gerald M Feldman
CFO & Secretary
|
CFO & Secretary | Total investments: 0 | Find email | |
|
Lynn Chapman
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Carl Data Solutions (CARL Data Solutions) is a publically listed company (CSE:CRL | FSE: 7C5) that develops next generation data collection, storage and analytic solutions for data-centric companies.CARL’s first acquisition was Extend to Social Media Inc., a company with an application that allows clients to leverage their customers’ socialnetworks for referral marketing and analytics.CARL has signed an agreement to acquire FlowWorks, a company that helps its clients analyze and understand all forms of environmental data through a powerful platform of data collection, monitoring, analysis, and reporting tools.CARL is creating a virtually unlimited data storage environment from which informative visual representations of data can be created. The goal of the company is to deliver a comprehensive data management solution for datasets of any size, type and complexity. | $434.9K / Post-IPO Debt / Oct 17, 2025 | ||
| Tenet Fintech Group is an innovative Fintech service provider to the Chinese commercial lending sector. | $2.5M / Post-IPO Equity / Mar 07, 2025 | ||
| Carl Data Solutions (CARL Data Solutions) is a publically listed company (CSE:CRL | FSE: 7C5) that develops next generation data collection, storage and analytic solutions for data-centric companies.CARL’s first acquisition was Extend to Social Media Inc., a company with an application that allows clients to leverage their customers’ socialnetworks for referral marketing and analytics.CARL has signed an agreement to acquire FlowWorks, a company that helps its clients analyze and understand all forms of environmental data through a powerful platform of data collection, monitoring, analysis, and reporting tools.CARL is creating a virtually unlimited data storage environment from which informative visual representations of data can be created. The goal of the company is to deliver a comprehensive data management solution for datasets of any size, type and complexity. | $520K / Post-IPO Debt / Feb 10, 2023 | ||
| Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered.Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation ofcellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells. | Venture - Series Unknown / Apr 11, 2022 | ||
| XREX is a neo-fintech leveling the playing field by partnering with banks, regulators, and verified individuals to redefine banking together. Our blockchain-driven solutions create a collective financial system that empowers all to participate and contribute to the global economy. Founded in 2018 and headquartered in Taipei, XREX comprises a teamof world-leading experts in cybersecurity, fintech, compliance, and cryptocurrency to offer a full suite of innovative products such as BitCheck, XREX Circles, Risk Level Detector to solve the dollar-liquidity shortage issues faced by cross-border merchants in emerging economies. | $17M / Seed / Apr 20, 2021 | ||
| M2bio Sciences Inc. formerly Wuhan General Group, Inc. is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms based products under Dr. AnnaRx™, Medspresso™ and Handcrafted Delights™ brands. In addition, our research andclinical trials with psilocybin are aimed for new therapies that will help patients who suffer from alcohol addiction, mental illness and heart diseases. | $450K / Post-IPO Equity / Dec 30, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does ThreeD Capital invest in?
ThreeD Capital invests primarily in Information Technology, FinTech and Health Care startups, most often at Post-IPO Equity and Seed stage. Most of the 6 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does ThreeD Capital invest in?
ThreeD Capital typically joins rounds of $435k–$520k at Post-IPO Debt and $450k–$2.5M at Post-IPO Equity. These are whole funding-round sizes, not ThreeD Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds ThreeD Capital took part in.
How do I contact ThreeD Capital?
Public channels for ThreeD Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at ThreeD Capital?
The team at ThreeD Capital includes Sheldon Inwentash (Chairman, CEO, & CIO), Gerald M Feldman (CFO & Secretary) and Lynn Chapman (Chief Financial Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
